Biomedical Omics Research
Biomedical Omics Research Bioconvergence Analysis > Major Research Activities Home
The Biomedical Omics Research Group is devoted to the development and application of “Omics” technologies based on mass spectrometry with an ultimate goal of understanding biology and solving environmental problem.
- Management of Mass Spectrometry Core Facility for Omics research
- Development of state-of-the-art mass spectrometry technology for MS experiments
- Application of proteomic technologies to target discovery in various diseases
Representative Research Cases
Identification of missing proteins from human olfactory epithelial tissue
- Using next-generation proteomic pipeline, we identified 5 missing proteins (ACSM4, SLCO1A2, BPIFB3, SAXO2, and SVOPL) from human olfactory epithelial tissue. We reported the discovery at World Congress of Human Proteome Organization and published in Journal of Proteome Research (2018, 17, 4320).
Using next-generation proteomic pipeline and high-resolution NanoLC-MS/MS, we identified 5 missing proteins and validated them with corresponding synthetic peptide analysis.